Literature DB >> 10233959

Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.

J Zhou1, W J Liu, S W Peng, X Y Sun, I Frazer.   

Abstract

Translation of mRNA encoding the L1 and L2 capsid proteins of papillomavirus (PV) is restricted in vivo to differentiated epithelial cells, although transcription of the L1 and L2 late genes occurs more widely. The codon composition of PV late genes is quite different from that of most mammalian genes. To test the possibility that PV late gene codon composition determines the efficiency of PV late gene expression in some cell types, synthetic bovine papillomavirus type 1 (BPV1) late genes were constructed with codon composition modified to resemble the typical mammalian gene. Expression of these genes from a strong promoter in Cos-1 cells was compared with expression of wild-type BPV1 late genes from the same promoter. Both unmodified and modified PV late genes were transcribed in Cos-1 cells, but only the codon-modified genes were translated. In vitro translation of wild-type but not synthetic BPV1 L1 mRNA was markedly enhanced by addition of aminoacyl-tRNAs. Codon composition thus limits BPV1 late gene translation in Cos-1 cells, and this limitation can be overcome by modification of the codon composition of the genes or by provision of excess tRNA. Replacement of codons in the green fluorescent protein (gfp) gene with those frequently used in PV late genes did not alter gfp transcription in Cos-1 cells but almost abolished translation, supporting the hypothesis that the observed differences in efficiency of translation of modified and unmodified PV capsid genes were related to codon usage rather than mRNA structure. As tRNA populations vary within and between tissues in the same eukaryotic organism, we speculate that matching of tRNA availability to codon usage may be one determinant of the restriction of expression of PV late genes to differentiated epithelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233959      PMCID: PMC112541     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Translation in vitro of codon UGA as tryptophan in Mycoplasma capricolum.

Authors:  T Oba; Y Andachi; A Muto; S Osawa
Journal:  Biochimie       Date:  1991 Jul-Aug       Impact factor: 4.079

2.  A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein.

Authors:  J Zhou; J Doorbar; X Y Sun; L V Crawford; C S McLean; I H Frazer
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

5.  Isoaccepting +RNA's in mouse plasma cell tumors that synthesize different myeloma protein.

Authors:  W K Yang; G D Novelli
Journal:  Biochem Biophys Res Commun       Date:  1968-05-23       Impact factor: 3.575

6.  Pattern of valine transfer ribonucleic acid of Bacillus subtilis under different growth conditions.

Authors:  R H Doi; I Kaneko; R T Igarashi
Journal:  J Biol Chem       Date:  1968-03-10       Impact factor: 5.157

7.  An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels.

Authors:  P A Furth; C C Baker
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Authors:  D Smotkin; F O Wettstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

Authors:  J Zhou; X Y Sun; D J Stenzel; I H Frazer
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

10.  Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues.

Authors:  C C Baker; P M Howley
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

View more
  98 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

4.  Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Authors:  Daniel Oberg; Brian Collier; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Level of gene expression is a major determinant of protein evolution in the viral order Mononegavirales.

Authors:  Israel Pagán; Edward C Holmes; Etienne Simon-Loriere
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Maturation of papillomavirus capsids.

Authors:  Christopher B Buck; Cynthia D Thompson; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo.

Authors:  Kong-Nan Zhao; WenYi Gu; Ning Xia Fang; Nicholas A Saunders; Ian H Frazer
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

8.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  The signature of selection mediated by expression on human genes.

Authors:  Araxi O Urrutia; Laurence D Hurst
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

10.  Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids.

Authors:  M Isabel Costafreda; Francisco J Pérez-Rodriguez; Lucía D'Andrea; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.